Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.720
-1.170 (-40.48%)
At close: May 9, 2025, 4:00 PM
1.770
+0.050 (2.91%)
After-hours: May 9, 2025, 6:18 PM EDT

Protalix BioTherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1341381306938118
Upgrade
Market Cap Growth
117.03%6.60%87.08%83.20%-68.02%143.47%
Upgrade
Enterprise Value
1051171158226141
Upgrade
Last Close Price
1.721.881.781.370.833.63
Upgrade
PE Ratio
40.0147.2115.62---
Upgrade
Forward PE
3.193.94-60.89--
Upgrade
PS Ratio
2.112.591.981.460.991.88
Upgrade
PB Ratio
3.033.203.87-6.52-6.28-4.38
Upgrade
P/TBV Ratio
2.973.203.87---
Upgrade
P/FCF Ratio
-18.73----
Upgrade
P/OCF Ratio
-15.96----
Upgrade
EV/Sales Ratio
1.752.191.751.720.682.24
Upgrade
EV/EBITDA Ratio
17.5822.359.86--35.08
Upgrade
EV/EBIT Ratio
22.6329.8010.98--51.93
Upgrade
EV/FCF Ratio
-15.79----
Upgrade
Debt / Equity Ratio
0.120.130.78-3.15-5.54-2.38
Upgrade
Debt / EBITDA Ratio
0.690.812.00--11.94
Upgrade
Debt / FCF Ratio
-0.75----
Upgrade
Asset Turnover
0.730.680.930.740.541.11
Upgrade
Inventory Turnover
1.431.211.281.131.051.02
Upgrade
Quick Ratio
1.621.491.110.841.290.48
Upgrade
Current Ratio
2.492.351.541.381.860.64
Upgrade
Return on Equity (ROE)
10.42%7.64%72.50%---
Upgrade
Return on Assets (ROA)
3.53%3.10%9.32%-12.57%-18.06%2.99%
Upgrade
Return on Capital (ROIC)
5.43%4.51%15.81%-32.36%-39.47%12.11%
Upgrade
Return on Capital Employed (ROCE)
9.30%8.20%26.90%---
Upgrade
Earnings Yield
2.91%2.12%6.40%-21.50%-72.80%-5.50%
Upgrade
FCF Yield
-1.16%5.34%-1.90%-36.92%-31.00%-22.59%
Upgrade
Buyback Yield / Dilution
5.05%1.66%-70.04%-9.81%-51.43%-96.44%
Upgrade
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q